Human-AI coaching models boost weight loss
Adding human coaches to artificial intelligence-powered weight-loss programs significantly boosts user success, underscoring the value of hybrid human-AI models in digital health, a new study suggests.
Study finds orforglipron taken orally once daily leads to significant body weight loss
New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15–19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes.
Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.
Study suggests new drug for weight loss may cause fewer side effects
A new Penn Nursing study suggests that the weight-loss drug tirzepatide may cause fewer side effects like nausea and vomiting than the drug semaglutide. This research, published in Science Advances, was conducted using preclinical models to study the effects of the drugs.
Pill form of semaglutide may be a suitable option for adults with overweight or obesity, trial suggests
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity.
- Bayville
- Toms River
- Book an appointment
Healthcare News
Locations & Directions
-
- Bayville
275 Atlantic City Blvd.
Bayville, NJ 08721 - Get Directions
- Book an appointment
- Bayville
-
- Tom River
20 Hospital Drive Ste. 3
Toms River, 08755 - Get Directions
- Book an appointment
- Tom River